Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,756 · see citing works

Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent

Sedlak, J., & Lindsay, R. H. (1968) · Analytical Biochemistry · doi:10.1016/0003-2697(68)90092-4 · Cited by 8,092 · see citing works

A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis

Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S. K., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,506 · see citing works

Towards a network theory of the immune system.

Nk, J. (1974) · PubMed · Cited by 3,388 · see citing works

Global atlas on cardiovascular disease prevention and control.

Mendis, S., Puska, P., & Norrving, B. G. (2011) · Virtual Defense Library (Ministerio de Defensa) · Cited by 2,691 · see citing works

Role of Oxidative Modifications in Atherosclerosis

Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,611 · see citing works

Atherosclerosis: Basic Mechanisms

Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,726 · see citing works

The Response-to-Retention Hypothesis of Early Atherogenesis

Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413 · see citing works

Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications

Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399 · see citing works

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019 · see citing works

A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis

Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S. K., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1512 · Cited by 959 · see citing works

Fc receptor but not complement binding is important in antibody protection against HIV

Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J. M., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 899 · see citing works

Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease

Holvoet, P., Vanhaecke, J., Janssens, S., de Werf, F. V., & Collen, D. (1998) · Circulation · doi:10.1161/01.cir.98.15.1487 · Cited by 673 · see citing works

The Use of the Avidin‐Biotin Complex as a Tool in Molecular Biology

Bayer, E. A., & Wilchek, M. (1980) · Methods of biochemical analysis · doi:10.1002/9780470110461.ch1 · Cited by 607 · see citing works

Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction

Granger, D. L., Taintor, R. R., Boockvar, K. S., & Hibbs, J. B. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)68016-1 · Cited by 511 · see citing works

Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease

Drüeke, T. B., Witko‐Sarsat, V., Massy, Z. A., Descamps‐Latscha, B., Guérin, A. P., Marchais, S. J., Gausson, V., & London, G. M. (2002) · Circulation · doi:10.1161/01.cir.0000035250.66458.67 · Cited by 375 · see citing works

Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.

Borén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · see citing works

Glutathione, Stress Responses, and Redox Signaling in Lung Inflammation

Rahman, I., Biswas, S. K., Jimenez, L. A., Torrès, M., & Forman, H. J. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.42 · Cited by 297 · see citing works

Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: Possible application to vaccine production

Nisonoff, A., & Lamoyi, E. (1981) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(81)90228-2 · Cited by 296 · see citing works

Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences

Fredrikson, G. N., Söderberg, I., Lindholm, M., Dimayuga, P. C., Chyu, K., Shah, P. K., & Nilsson, J. Å. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000067937.93716.db · Cited by 261 · see citing works

AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients

Witko‐Sarsat, V., Gausson, V., Nguyen, A., Touam, M., Drüeke, T. B., Santangelo, F., & Descamps‐Latscha, B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00044.x · Cited by 233 · see citing works

Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity

Mateo, C., Moreno, E., Amour, K., Lombardero, J., Harris, W. J., & érez, R. (1997) · Immunotechnology · doi:10.1016/s1380-2933(97)00065-1 · Cited by 191 · see citing works

Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells.

Hurt‐Camejo, E., Camejo, G., Rosengren, B. E., López, F., Ahlström, C., Fager, G., & Bondjers, G. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.5.569 · Cited by 184 · see citing works

Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.

Hurt‐Camejo, E., Camejo, G., Rosengren, B. E., Lopez, F., Wiklund, O., & Bondjers, G. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42610-0 · Cited by 162 · see citing works

Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond

Pendse, A. A., Arbones-Mainar, J. M., Johnson, L. A., Altenburg, M. K., & Maeda, N. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800070-jlr200 · Cited by 155 · see citing works

The safety and immunogenicity of a CETP vaccine in healthy adults

Davidson, M. H., Maki, K. C., Umporowicz, D. M., Wheeler, A., Rittershaus, C. W., & Ryan, U. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00137-0 · Cited by 131 · see citing works

Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis

Khalil, M. F., Wagner, W. D., & Goldberg, I. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000147163.54024.70 · Cited by 125 · see citing works

Aortic antioxidant defence mechanisms: time-related changes in cholesterol-fed rabbits

Boccio, G. D., Lapenna, D., Porreca, E., Pennelli, A., Savini, F., Feliciani, P., Ricci, G., & Cuccurullo, F. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90019-f · Cited by 123 · see citing works

Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis

Patel, R. P. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00086-9 · Cited by 116 · see citing works

An Anti-Idiotype Vaccine Elicits a Specific Response to N-Glycolyl Sialic Acid Residues of Glycoconjugates in Melanoma Patients

Alfonso, M., Díaz, A., Hernández, A., Perez‐Gonzalez, A., Rodríguez, E., Bitton, R. J., Pérez, R., & Vázquez, A. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2523 · Cited by 114 · see citing works

Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation.

Kanazawa, K., Kawashima, S., Mikami, S., Miwa, Y., Hirata, K., Suematsu, M., Hayashi, Y., Itoh, H., & Yokoyama, M. (1996) · Europe PMC (PubMed Central) · Cited by 105 · see citing works

Generation of a Murine Monoclonal Antibody Specific for N -Glycolylneuraminic Acid-Containing Gangliosides That Also Recognizes Sulfated Glycolipids

Vázquez, A. M., Alfonso, M., Lanne, B., Karlsson, K. ‐., Carr, A., Barroso, O., Fernandez, L. E., Rengifo, E., Lanio, M. E., Álvarez, C., et al. (1995) · Hybridoma · doi:10.1089/hyb.1995.14.551 · Cited by 96 · see citing works

Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease

Inoue, T., Uchida, T., Kamishirado, H., Takayanagi, K., Hayashi, T., & Morooka, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01199-2 · Cited by 95 · see citing works

Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody

Hernández, A., Toledo, D., Martínez, D., Griñán, T., Brito, V., Macias, A. E., Alfonso, S., Rondón, T., Suárez, E., Vázquez, A. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6625 · Cited by 93 · see citing works

An Animal Model to Study Local Oxidation of LDL and Its Biological Effects in the Arterial Wall

Calara, F. B., Dimayuga, P. C., Niemann, A., Thyberg, J., Diczfalusy, U., Witztum, J. L., Palinski, W., Shah, P. K., Cercek, B., Nilsson, J., et al. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.6.884 · Cited by 84 · see citing works

Syngeneic Anti-Idiotypic Monoclonal Antibodies to an Anti-NeuGc-Containing Ganglioside Monoclonal Antibody

VÁZQUEZ, A. M., PÉREZ, A., Hernández, A., MACÍAS, A., Alfonso, M., Bombino, G., & Pérez, R. (1998) · Hybridoma · doi:10.1089/hyb.1998.17.527 · Cited by 78 · see citing works

1E10 anti-idiotype vaccine in non-small cell lung cancer: Experience in stage IIIb/IV patients.

Alfonso, S., Díaz, R. M., de la Torre, A., Santiesteban, E. R., Aguirre, F., Pérez, K., Rodríguez, J. L., Barroso, M. C., Hernández, A. M., Toledo, D., et al. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.12.5000 · Cited by 76 · see citing works

ApoE−/−Fas−/− C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia

Feng, X., Li, H., Rumbin, A. A., Wang, X., Cava, A. L., Brechtelsbauer, K., Castellani, L. W., Witztum, J. L., Lusis, A. J., & Tsao, B. P. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600512-jlr200 · Cited by 73 · see citing works

Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis.

Little, P. J., Ballinger, M. L., & Osman, N. (2007) · PubMed Central · Cited by 69 · see citing works

Effect of Pravastatin on Malondialdehyde-Modified Low-Density Lipoprotein Levels and Coronary Plaque Regression as Determined by Three-Dimensional Intravascular Ultrasound

Tani, S., Watanabe, I., Anazawa, T., Kawamata, H., Tachibana, E., Furukawa, K., Sato, Y., Nagao, K., Kanmatsuse, K., & Kushiro, T. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.05.069 · Cited by 62 · see citing works

Superoxide dismutase and catalase inhibit oxidized low-density lipoprotein-induced human aortic smooth muscle cell proliferation: Role of cell-cycle regulation, mitogen-activated protein kinases, and transcription factors

Lin, S., Shyue, S., Shih, M.-C. M., Chu, T., Chen, Y., Ku, H., Chen, J., Tam, K.-B., & Chen, Y. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.044 · Cited by 58 · see citing works

Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis

Zeng, X., Chen, J., Miller, Y. I., Javaherian, K., & Moulton, K. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500241-jlr200 · Cited by 57 · see citing works

Proteoglycan mediated lipoprotein retention: A mechanism of diabetic atherosclerosis

Tannock, L. R., & King, V. L. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9078-0 · Cited by 57 · see citing works

Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion

Yuan, Z., Kishimoto, C., Sano, H., Shioji, K., Xu, Y. Y., & Yokode, M. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00926.2002 · Cited by 47 · see citing works

Biosynthesis of Natural and Hyperelongated Chondroitin Sulfate Glycosaminoglycans: New Insights into an Elusive Process

Little, P. J., Ballinger, M. L., Burch, M. L., & Osman, N. (2008) · The Open Biochemistry Journal · doi:10.2174/1874091x00802010135 · Cited by 45 · see citing works

Proteoglycans in macrophages: characterization and possible role in the cellular uptake of lipoproteins

Halvorsen, B. L., Une, K., Kulseth, M. A., Drevon, C. A., Christiansen, E. N., & Kolset, S. O. (1998) · Biochemical Journal · doi:10.1042/bj3310743 · Cited by 38 · see citing works

Apolipoprotein A-I/HDL Infusion Therapy for Plaque Stabilization-Regression: A Novel Therapeutic Approach

Shah, P. K. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780487520 · Cited by 35 · see citing works

A new model for arteriosclerosis An electron-microscopic study of the lesions induced by i.v. administered fat

Jellinek, H., Hársing, J., & Füzesi, S. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90095-8 · Cited by 28 · see citing works

Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody

Fernández‐Marrero, Y., Hernández, T., Roque-Navarro, L., Talavera, A., Moreno, E., Griñán, T., Vázquez, A. M., de Acosta, C. M., Pérez, R., & López‐Requena, A. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.01.008 · Cited by 27 · see citing works

Role of Macrophage Glycosaminoglycans in the Cellular Catabolism of Oxidized LDL by Macrophages

Kaplan, M., Williams, K. J., Mandel, H., & Aviram, M. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.4.542 · Cited by 27 · see citing works

Chimeric Anti- N -Glycolyl-Ganglioside and Its Anti-Idiotypic MAbs: Immunodominance of Their Variable Regions

López‐Requena, A., de Acosta, C. M., Perez‐Gonzalez, A., Garay, A. V., Lombardero, J., Sosa, K., Pérez, R., & Vázquez, A. M. (2003) · Hybridoma and Hybridomics · doi:10.1089/153685903322328965 · Cited by 26 · see citing works

Lipofundin-Induced Hyperlipidemia Promotes Oxidative Stress and Atherosclerotic Lesions in New Zealand White Rabbits

Delgado-Roche, L., Medina, E. A., Pérez, Á. F., Viart, M. D. L. Á. B., Soto, Y., Cama, V. F., López, A. M. V., Martı́nez-Sánchez, G., & Fernández-Sánchez, E. M. (2011) · International Journal of Vascular Medicine · doi:10.1155/2012/898769 · Cited by 26 · see citing works

Gangliosides, Ab1 and Ab2 antibodies

López‐Requena, A., de Acosta, C. M., Moreno, E., González, M., Puchades, Y., Talavera, A., Vispo, N. S., Vázquez, A. M., & Pérez, R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.02.020 · Cited by 25 · see citing works

Influence of artificial fat emulsions on the composition of serum lipoproteins in humans

Hailer, S., & Wolfram, G. (1986) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/43.2.225 · Cited by 21 · see citing works

Experimental immunotherapeutic approaches for atherosclerosis

Amir, S., & Binder, C. J. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.009 · Cited by 20 · see citing works

Interactions of Lipoproteins with Proteoglycans

Williams, K. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-209-0:457 · Cited by 17 · see citing works

[Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention].

Hurt‐Camejo, E., & Camejo, G. (2001) · PubMed · Cited by 3 · see citing works

[Trisomy 21. Report of 2 cases with unusual karyotypes].

Sánchez, O., de Marade, S., & Guerra, D. (2001) · PubMed · Cited by 2 · see citing works

Por qué son aterogénicas las lipoproteínas apoB del plasma: la hipótesis de respuesta a la retención

Camejo, E. H., & Camejo, G. (2001) · Investigación Clínica · Cited by 2 · see citing works

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works

A role for proteoglycans in vascular disease

Wight, T. N. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.019 · Cited by 161 · see citing works

Biological functions of iduronic acid in chondroitin/dermatan sulfate

Thelin, M. A., Bartolini, B., Axelsson, J. B., Gustafsson, R., Tykesson, E., Pera, E. M., Oldberg, Å., Maccarana, M., & Malmström, A. (2013) · FEBS Journal · doi:10.1111/febs.12214 · Cited by 134 · see citing works

Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease

Xu, L.-N., Yang, Q., & Zhou, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158465 · Cited by 67 · see citing works

LDL as a Cause of Atherosclerosis

TOMKIN, G. H. (2012) · The Open Atherosclerosis & Thrombosis Journal · doi:10.2174/1876506801205010013 · Cited by 61 · see citing works

Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix

Neufeld, E. B., Zadrozny, L. M., Phillips, D. J., Aponte, A. M., Yu, Z., & Balaban, R. S. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.038 · Cited by 52 · see citing works

Smooth Muscle Cell—Macrophage Interactions Leading to Foam Cell Formation in Atherosclerosis: Location, Location, Location

Xiang, P., Blanchard, V., & Francis, G. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.921597 · Cited by 50 · see citing works

Overfeeding Saturated Fat Increases LDL (Low-Density Lipoprotein) Aggregation Susceptibility While Overfeeding Unsaturated Fat Decreases Proteoglycan-Binding of Lipoproteins

Ruuth, M. K., Lahelma, M., Luukkonen, P. K., Lorey, M. B., Qadri, S. U., Sädevirta, S., Hyötyläinen, T., Kovanen, P. T., Hodson, L., Yki‐Järvinen, H., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315766 · Cited by 38 · see citing works

VSMCs in atherosclerosis: Implications on the role of inflammation and extracellular matrix remodelling

Jarad, S., Gill, G. S., Amadi, P. U., Gu, H.-M., & Zhang, D. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107833 · Cited by 40 · see citing works

Induction of Anti-Anti-Idiotype Antibodies Against Sulfated Glycosaminoglycans Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice

Brito, V., Mellal, K., Portelance, S. G., Pérez, A., Soto, Y., deBlois, D., Ong, H., Marleau, S., & Vázquez, A. M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300444 · Cited by 34 · see citing works

The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis

Francis, G. A. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01145-8 · Cited by 34 · see citing works

Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: Implications for lipoprotein binding and atherosclerosis

Afroz, R., Cao, Y., Rostam, M. A., Ta, H. T., Xu, S., Zheng, W., Osman, N., Kamato, D., & Little, P. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.005 · Cited by 33 · see citing works

Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins

Araujo, G., Valencia, L. M., Martin-Ozimek, A., Soto, Y., & Proctor, S. D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1485801 · Cited by 29 · see citing works

Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice

Delgado-Roche, L., Brito, V., Acosta, E., Pérez, A., Fernández, J. R., Hernández-Matos, Y., Griñán, T., Soto, Y., León, O. S., Marleau, S., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.027 · Cited by 21 · see citing works

Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis

Lhoëst, M. T. L. C., Martinez, A., Claudi, L., Garcia, E., Benitez‐Amaro, A., Polishchuk, A., Piñero, J., Viladés, D., Palmero, M. J. G., Sanz, F., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1381520 · Cited by 22 · see citing works

Smooth Muscle Cell-Proteoglycan-Lipoprotein Interactions as Drivers of Atherosclerosis

Allahverdian, S., Ortega, C., & Francis, G. A. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_364 · Cited by 20 · see citing works

A bibliometric analysis of immunotherapy for atherosclerosis: trends and hotspots prediction

Wang, J., Pan, G.-R., & Jiang, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1493250 · Cited by 16 · see citing works

The treatment with an anti-glycosaminoglycan antibody reduces aortic oxidative stress in a rabbit model of atherosclerosis

Delgado-Roche, L., Acosta, E., Soto, Y., Hernández-Matos, Y., Olivera, A., Fernández-Sánchez, E. M., & Vázquez, A. M. (2013) · Free Radical Research · doi:10.3109/10715762.2013.772995 · Cited by 16 · see citing works

Response to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical review

Kumarapperuma, H., Chia, Z.-J., Malapitan, S. M., Wight, T. N., Little, P. J., & Kamato, D. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118552 · Cited by 16 · see citing works

Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody

Soto, Y., Mesa, N., Marín, Y. A., Pérez, A., Batlle, F., Griñán, T., Pino, A., Viera, J., Frómeta, M., Brito, V., et al. (2014) · mAbs · doi:10.4161/mabs.29970 · Cited by 15 · see citing works

Interaction of arterial proteoglycans with low density lipoproteins (LDLs): From theory to promising therapeutic approaches

Kang, H., Lu, J., Yang, J., Fan, Y., & Deng, X. (2019) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2019.100016 · Cited by 14 · see citing works

New targets for glycosaminoglycans and glycosaminoglycans as novel targets

Gesslbauer, B., Theuer, M., Schweiger, D., Adage, T., & Kungl, A. J. (2013) · Expert Review of Proteomics · doi:10.1586/epr.12.75 · Cited by 13 · see citing works

Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE−/− Mice: Association with Atheroprotection

Sarduy, R., Brito, V., Castillo, A., Soto, Y., Griñán, T., Marleau, S., & Vázquez, A. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00232 · Cited by 12 · see citing works

Gua Lou Er Chen decoction attenuates atherosclerosis by reducing proteoglycans accumulation and inflammation

Guo, H., Li, Y., Qiu, L., Li, J., Guo, X., Zhang, Y., & Wang, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154811 · Cited by 10 · see citing works

Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice

Brito, V., Mellal, K., Zoccal, K. F., Soto, Y., Ménard, L., Sarduy, R., Faccioli, L. H., Ong, H., Vázquez, A. M., & Marleau, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00782 · Cited by 10 · see citing works

Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin‐Resistant Rats: Acute Treatment Versus Long‐Term Protection as an Idiotypic Vaccine for Atherosclerosis

Soto, Y., Hernández, A., Sarduy, R., Navarro, V. B., Marleau, S., Vine, D. F., Vázquez, A. M., & Proctor, S. D. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032419 · Cited by 5 · see citing works

Development and application of targeted therapeutic protein conjugates

Maksimenko, A. V. (2014) · Russian Journal of General Chemistry · doi:10.1134/s1070363214020376 · Cited by 5 · see citing works

New Alternatives for Atherosclerosis Treatment Based on Immunomodulation

Roche, L. D., & Hernández, D. A. (2012) · ISRN Vascular Medicine · doi:10.5402/2012/785094 · Cited by 3 · see citing works

Anti‐Idiotypic Antibodies

López‐Requena, A., Burrone, Ó. R., & Pérez, R. (2014) · doi:10.1002/9783527682423.ch16 · Cited by 2 · see citing works

The response-to-retention hypothesis: From theory to the potential therapeutic approaches

Delgado-Roche, L. (2014) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2014.08.001 · Cited by 1 · see citing works

Diagnosis and Treatment of Atherosclerosis: A Review Article

El‐Agamy, D. S., Said, E., Abo‐Haded, H. M., & Arabia, S. (2015) · Cited by 1 · see citing works

Kupffer cells dictate hepatic responses to the atherogenic dyslipidemic insultPreprint

Hellberg, S., Ahmed, O., Zhang, Y., Nunzio, G. D., Björck, H. M., Francis, R., Fagerberg, L., Gisterå, A., Zhang, X., Metso, J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.13.512086 · Cited by 1 · see citing works

Inhibition of macrophage metabolism by oxLDL

Katouah, H. A. (2012) · UC Research Repository (University of Canterbury) · doi:10.26021/6511

EL TRATAMIENTO CON EL ANTICUERPO MONOCLONAL CHP3R99 DISMINUYE LA INFILTRACIÓN DE MACRÓFAGOS EN LA ÍNTIMA ARTERIAL DE CONEJOS NZB.

Delgado-Roche, L., Acosta, E., Soto, Y., Hernández-Matos, Y., Bécquer, M. A., Álvarez, D., Fernández-Sánchez, E. M., Vázquez, A., & Delgado-Roche, C. L. (2015) · Revista de Ciencias Farmacéuticas y Alimentarias

EL TRATAMIENTO CON EL ANTICUERPO ANTI-PROTEOGLICANO CHP3R99 NO AFECTA LA BIOENERGÉTICA MITOCONDRIAL EN RATONES

Delgado-Roche, L., Hernández-Matos, Y., Simón, G. G., López, A. M., & Pardo‐Andreu, G. L. (2015) · Revista de Ciencias Farmacéuticas y Alimentarias

Lipid: Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes

Kamato, D., & Little, P. J. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_12

Monoclonal antibody chP3R99 reduces subendothelial retention of atherogenic lipoproteins in Insulin-Resistant rats: Acute treatment versus long-term protection as an idiotypic vaccine for atherosclerosisPreprint

Soto, Y., Hernández, A., Sarduy, R., Brito, V., Marleau, S., Vine, D. F., Vázquez, A. M., & Proctor, S. D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.555546

Characterization and Antiatherogenic Potential of P3R99 Monoclonal Antibody Against Sulfated Glycosaminoglycans: Physicochemical and Functional InsightsPreprint

Valencia, L. M., Martínez-Montano, Y., Gómez, J. A., Sarduy, R., Hernández, A., Proctor, S. D., Fernández-Calienes, A., Brito, V., & Soto, Y. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.09.612153

Study on the Anti-Inflammatory Activity of Chondroitin Sulfate-Curcumin Amphiphilic Polymers

高, 继. (2025) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2025.154081

A la recherche d’anticorps humains et de nouveaux biomarqueurs pour le ciblage de la plaque d’athérome

Hémadou, A. (2017) · doi:10.70675/1c2fc378zb806z46b2zafb9z47a32f1c994c

Rôle de la phosphatase alcaline non spécifique du tissu "TNAP" dans la calcification des plaques d’athérosclérose

Kawtharany, L. (2022) · theses.fr (ABES) · doi:10.70675/8266a539zd176z4839zb688z6235f93ffe7c

Integrative Physiology/Experimental Medicine Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans

Soto, Y., Acosta, E., Delgado, L., Bécquer, M. A., Fraga, A. N., Brito, V., Lvarez, I. A., Noa, M., & Vázquez, A. M. (2016)

A potential idiotipic vaccine for the treatment of atherosclerosis based on a chimeric mouse/human anti-sulfated glycosaminoglycans antibody

Soto, Y., Acosta, E., Delgado-Roche, L., Pérez, A., Mesa, N., Marín, Y. A., Batlle, F., Bécquer, M. A., Griñán, T., Brito, V., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.1053

Arresting atherosclerosis development and progression by immunization with an anti-glycosaminoglycan chimeric monoclonal antibody in apolipoprotein E-deficient mice

Brito, V., Delgado, L., Mellal, K., Soto, Y., Acosta, E., Pérez, A., Fernández, J. R., Griñán, T., Bécquer, M. A., Marleau, S., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.317

The treatment with an anti-glycosaminoglycan antibody reduces aortic oxidative stress in a rabbit model of atherosclerosis

Delgado-Roche, L., Acosta, E., Soto, Y., Hernández-Matos, Y., Olivera, A., Fernández-Sánchez, E. M., & Vázquez, A. M. (2013) · Free Radical Research · doi:10.3109/10715762.2013.772995 · Cited by 16 · see citing works

Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice

Delgado-Roche, L., Brito, V., Acosta, E., Pérez, A., Fernández, J. R., Hernández-Matos, Y., Griñán, T., Soto, Y., León, O. S., Marleau, S., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.027 · Cited by 21 · see citing works